Loading...
Loading...
Hikma Pharmaceuticals Plc
HKMPY reported a 19% surge in its full-year profit.
Hikma's profit attributable to shareholders climbed to $120.5 million, up from $100.9 million in the year-ago period.
Its revenue rose 21% to $1.11 billion.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
